It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2012.
2012 | Bangalore, Karnataka, India | Struck OffCanris Pharma India Private Limited, a struck off private limited company, was established on 28 March 2012 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85100KA2012PTC063264. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Chikkapura Shanthaveerappa Nagaraja (Director), Mohan Kumar Rajanna (Director), Mahantesh Rachayya Charantimath (Director). Past directors included Devarahally Karibasavashastry Jamuna, Venkatesh Prasanna Kumar. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 304, 3Rd Floor, Sri Lakshmi Residency Katriguppe Main Road, Bsk 3Rd Stage, Bangalore, Karnataka, 560085.
U85100KA2012PTC063264
063264
28 March 2012
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Struck Off
Explore comprehensive insights into Canris Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chikkapura Shanthaveerappa Nagaraja | Director | 28 Mar 2012 | Current |
| Mohan Kumar Rajanna | Director | 05 Dec 2016 | Current |
| Mahantesh Rachayya Charantimath | Director | 05 Dec 2016 | Current |
| Devarahally Karibasavashastry Jamuna | Director | 28 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Dec 2016 | Past |
| Pramod Abcsdd | Director | 02 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Canris Pharma India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Canris Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Canris Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Canris Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canris Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Canris Pharma India Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Canris Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore. was recorded as a recent event.
Progress on Mohan Kumar Rajanna was appointed as a Director was appointed as a Director on 05 Dec 2016 & has been associated with this company since 8 years 11 months . was documented.
The activity Mahantesh Rachayya Charantimath was appointed as a Director was appointed as a Director on 05 Dec 2016 & has been associated with this company since 8 years 11 months . was completed.
The activity Chikkapura Shanthaveerappa Nagaraja was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 13 years 7 months . was completed.
The activity Devarahally Karibasavashastry Jamuna was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 13 years 7 months . was completed.
The CIN of Canris Pharma India Private Limited is U85100KA2012PTC063264.
Canris Pharma India Private Limited is headquartered at 304, 3Rd Floor, Sri Lakshmi Residency Katriguppe Main Road, Bsk 3Rd Stage, Bangalore, Karnataka, 560085.
Canris Pharma India Private Limited was incorporated on 28 March 2012.
The current directors of Canris Pharma India Private Limited are
The primary industry of Canris Pharma India Private Limited is Trade.
Canris Pharma India Private Limited is unlisted.
The authorized capital of Canris Pharma India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Canris Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX